Risk of adverse pregnancy outcomes following inadvertent exposure to ivermectin during the periconception period: findings from two cluster-randomized trials in Mozambique and Kenya.Nicolas, P. Mundaca, H. Brazeal, A. Houana, A. Ngama, M. Macucha, A. Matano, A. Elobolobo, E. Vegove, V. Martinho, S. Kariuki, M. Mbanze, J. Mitora, S. Montana, J. Ringera, I. Tunez, L. Imputiua, S. Munguambe, H. Mutepa, V. Soares, A. Xerinda, A. Materrula, F. Ruiz-Castillo, P. Onyango, T. Casellas, A. Rudd, M. Jones, C. Maia, M. Mwangangi, J. Rabinovich, R. Saute, F. Chaccour, C.
EClinicalMedicine, (2026). 97:104069